Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07783711 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07783711 · ClinicalTrials.gov record · last posted 2026-08-26

Predictors of ICU Admission and In-Hospital Mortality in Hospitalized Patients With Lupus Nephritis: The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and C Reactive Protein to Serum Albumin Ratio

StatusNot Yet Recruiting
PhaseNot specified
Started2026-09
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
To identify clinical and laboratory predictors of ICU admission and in-hospital mortality among hospitalized adults with lupus nephritis by evaluating the prognostic performance of NLR and CAR, comparing them with CRP and albumin using ROC analysis, determining optimal cutoff values, and identifying independent predictors through multivariable logistic regression

Protocol amendment history 1 change detected by DataLookout

2026-08-27
Primary endpoint(s) modified
WasICU admission or In-hospital mortality.
NowNumber of participants of ICU admission or In-hospital mortality.
Trial Details
NCT Number NCT07783711
Lead Sponsor Khaled Samir Malak Nashed
Collaborators: Assiut University
Conditions Lupus Nephritis (LN)
Enrollment 55 participants
Start Date 2026-09
Primary Completion 2028-09-01 (estimated)
Study Completion 2028-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-26